Overview

A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

Status:
Recruiting

Trial end date:
2025-08-20

Target enrollment:
0

Participant gender:
All

Summary

One of the most frequent skin conditions is atopic dermatitis (AD), characterized by its pruritic inflammation effect. Where the prevalence of AD increased in the last three decades by two or three folds worldwide, especially in developed countries, AD is supposed to affect about 15% to 30% of children, and 2% to 10% of adults. This type of dermatitis is frequently linked to a family history of other atopic illnesses such as allergic rhinitis or asthma.

Phase:

Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Tanta University

Treatments:

Hydrocortisone
Tacrolimus

Criteria

Inclusion Criteria:

- Male or female, 2-16 years old AD patients.

Exclusion Criteria:

- patients diagnosed with other skin disorders of serious type and who are taking
systemic corticosteroids or anti-inflammatory medications.